CEFTAZIDIME
Substance profile for UNII 9M416Z9QNR, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from NCI/CADD chemical resolverSubstance Identity#
- UNII
- 9M416Z9QNR
- Preferred term
- CEFTAZIDIME
- Registry number
- 78439-06-2
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C22H21N6O7S2.H.5H2O
Structure render from NCI/CADD chemical resolverChemical And Database Identifiers#
- InChIKey
- NMVPEQXCMGEDNH-TZVUEUGBSA-N
- SMILES
- [H+].O.O.O.O.O.CC(C)(O\N=C(/C(=O)N[C@H]1[C@H]2SCC(C[N+]3=CC=CC=C3)=C(N2C1=O)C([O-])=O)C4=CSC(N)=N4)C([O-])=O
- RxCUI
- 235552
- PubChem
- 0
- NCIt
- C66868
- INN ID
- 0
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| ACTIVE INGREDIENT | Ceftazidime for Injection, USP | 12 |
| ACTIVE INGREDIENT | Ceftazidime for Injection, USP | 12 |
| ACTIVE INGREDIENT | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 14 |
| ACTIVE INGREDIENT | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 13 |
| ACTIVE INGREDIENT | CEFTAZIDIME AND DEXTROSE (CEFTAZIDIME) INJECTION, SOLUTION [B. BRAUN MEDICAL INC.] | 11 |
| ACTIVE INGREDIENT | CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 6 |
| ACTIVE INGREDIENT | FORTAZ (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION FORTAZ (CEFTAZIDIME SODIUM) INJECTION, SOLUTION [COVIS PHARMACEUTICALS, INC.] | 5 |
| ACTIVE INGREDIENT | CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 4 |
| ACTIVE INGREDIENT | AVYCAZ (CEFTAZIDIME, AVIBACTAM) POWDER, FOR SOLUTION [FOREST LABORATORIES, INC.] | 2 |
| ACTIVE INGREDIENT | CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 2 |
| ACTIVE INGREDIENT | CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS] | 2 |
| ACTIVE INGREDIENT | CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 2 |
| ACTIVE INGREDIENT | CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [WG CRITICAL CARE, LLC] | 2 |
| ACTIVE INGREDIENT | TAZICEF (CEFTAZIDIME) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 2 |
| ACTIVE MOIETY | FORTAZ (CEFTAZIDIME) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [CARDINAL HEALTH] | 1 |